Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation | Zendy

Sanshuai Chang | Zendy; Jianzeng Dong | Zendy; Changsheng Ma | Zendy; Xin Du | Zendy; Jiahui Wu | Zendy; Ribo Tang | Zendy; Shijun Xia | Zendy; Xueyuan Guo | Zendy; Ronghui Yu | Zendy; Deyong Long | Zendy; Rong Bai | Zendy; Nian Liu | Zendy; Caihua Sang | Zendy; Chenxi Jiang | Zendy; Xiaohui Liu | Zendy; Jianhong Pan | Zendy; Gregory Y.H. Lip | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation

Author(s) -

Sanshuai Chang,

Jianzeng Dong,

Changsheng Ma,

Xin Du,

Jiahui Wu,

Ribo Tang,

Shijun Xia,

Xueyuan Guo,

Ronghui Yu,

Deyong Long,

Rong Bai,

Nian Liu,

Caihua Sang,

Chenxi Jiang,

Xiaohui Liu,

Jianhong Pan,

Gregory Y.H. Lip

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.012988

Subject(s) - medicine , atrial fibrillation , stroke (engine) , cardiology , ischemic stroke , oral anticoagulant , warfarin , ischemia , mechanical engineering , engineering

Reported rates of oral anticoagulation (OAC) use have been low among Chinese patients with atrial fibrillation (AF). With improved awareness, changing guidelines, this situation may be changing over time. We aimed to explore the current status and time trends of OAC use in Beijing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research